Literature DB >> 23234483

Predictive value from pediatrician plusoptix screening: impact of refraction and binocular alignment.

Robert W Arnold, Daniel Tulip, Erin McArthur, Janet Shen, John Tappel, Laura E Arnold, Elizabeth Winkle, M Diane Armitage.   

Abstract

BACKGROUND: The positive predictive value (PPV) of conventional preschool acuity screening is about 50% whereas previous Polaroid photoscreening with experienced interpretation can achieve PPV greater than 85%. The Plusoptix photoscreener has immediate computer interpretation and a CPT code available to pediatricians.
METHODS: Two Plusoptix SO9 were used in two pediatric group practices with previously validated refractive criteria and new manufacturer's binocular alignment criteria. CPT billing was monitored. Referred patients had prior gold-standard AAPOS examinations.
RESULTS: 12% of 675 photoscreened preschoolers were referred. Of the 39 with AAPOS gold-standard exams, the PPV from strabismus referrals was 17%, while 26 of 27 refractive referrals had true amblyopia risk factors (PPV 96%). Screening CPT code 99174 reimbursement rose from zero to half of insurers in 15 months.
CONCLUSION: Plusoptix photoscreening is valid after adjusting the binocular alignment criteria. Such photoscreening should be employed by pediatric practices to detect and ultimately to reduce amblyopia vision impairment in children.

Entities:  

Mesh:

Year:  2012        PMID: 23234483

Source DB:  PubMed          Journal:  Binocul Vis Strabolog Q Simms Romano        ISSN: 2160-5351


  2 in total

1.  Sensitivity and Specificity of Preschool Vision Screening in Iran.

Authors:  Hassan Hashemi; Abbasali Yekta; Ebrahim Jafarzadehpur; Hadi Ostadimoghaddam; Amir Asharlous; Payam Nabovati; Mehdi Khabazkhoob
Journal:  Iran J Public Health       Date:  2017-02       Impact factor: 1.429

2.  Instrument Referral Criteria for PlusoptiX, SPOT and 2WIN Targeting 2021 AAPOS Guidelines.

Authors:  Robert Arnold; David Silbert; Heather Modjesky
Journal:  Clin Ophthalmol       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.